Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| We can’t control that shadow, but we are more confident than ever about what lies behind it, in particular, platform, portfolio and balance sheet |
| Last evening, we reported a strong fourth quarter, both operationally and financially |
| From where we sit today, we’ve got some upside in occupancy on the operating portfolio |
| Public market volatility, notwithstanding, your collaboration and winning mindset allowed us to produce record leasing volumes in two of our three business segments and to exceed our initial same-store and earnings guidance by 130 basis points and $0.05 per share respectively |
| We have the highest level of confidence that this combination will in fact augment our platform capabilities, relationships, balance sheet and earnings |
| We have a pretty good track record of beating our same-store guidance and our earnings guidance |
| If we can outperform that time line, then we will have further upside to our outlook |
| So the next 10 years, as Scott said, is very optimistic |
| I think we delivered really strong AFFO growth this year at more than 5%, we grew FFO more than 7% the year before that, and we expect to continue that |
| On the other side of the spectrum, outpatient medical is growing at a higher rate than historical averages as demand is outstripping supply, a key thesis in our merger with DOC combined with the improved capabilities and significant synergies |
| We expect to benefit from sector fundamentals that have never been stronger, high-quality assets and operations and internalization |
| Most important, we believe we are combining the two best outpatient platforms in the country to create an even bigger and better company to drive internal and external growth for the next decade plus |
| Nothing grows to the sky in perpetuity, but we do like our market positioning and firmly believe we will outperform as sentiment and fundamentals improve |
| One of them is in Dallas, where we have had tremendous success |
| We see approximately $30 million of year-over-year earnings benefit from same-store growth |
| The fundamental drivers of long-term growth are solidly intact with both drug approvals and new drug applications at or near all-time highs |
| And where we sit today, we feel confident that we can hit those numbers |
| Fundamentals in outpatient medical continue to improve versus historical norms, including higher tenant retention, increased rent mark-to-market and increased escalators |
| Those dynamics will eventually turn in our favor and we’ll be well positioned to capitalize |
| The underlying fundamentals that Scott mentioned in his prepared remarks are strong indicators of future demand |
| We have got good assets, mostly in Florida, obviously, favorable supply/demand |
| Year-to-date, we have signed 58,000 feet of leases with another 115,000 feet under LOI plus active discussions across our portfolio, so an encouraging start to the year |
| So I would say, we are ahead of expectations in year 1 |
| The majority of these lease transactions were signed with existing relationships and we were also successful in capturing incremental demand from new tenants |
| We had a strong finish to the year, with 4.3% same-store growth, bringing full year growth to 3.4%, in line with the midpoint of our guidance range |
| So, I think that we are off to a strong start for the year |
| It’s not going to 10%, but we do think it’s going to improve for the forward 5 to 10 years versus the previous 5 to 10 years, just given supply demand, construction cost and therefore, our ability to push rents |
| We are well positioned when new development begins to pencil |
| Starting with our financial results, we finished the year on a strong note |
| In LCS, we have got a really strong internal team overseeing it |
| Statement |
|---|
| But keeping in mind, Scott’s bigger picture comment that it is down year-over-year from what we would have said a year ago just because of market fundamentals |
| Fortunately, even during the market exuberance for life science, we stuck to our strategy |
| If you try and back those out, you’d say our AFFO would be down year-over-year |
| Fourth, our current FFO outlook includes a negative $0.03 mark-to-market on the $1.9 billion of DOC debt that we will assume |
| And that’s really primarily because of the temporary lost NOI at the two large campuses I mentioned in the prepared remarks |
| But we are facing some headwinds |
| At the same time, venture capital deployment and the IPO market remains soft and boards are deferring leasing decisions when possible |
| So I just want to point out that same-store for lab will be a little bit weaker first half of the year versus second half |
| Some of those G&A savings are difficult |
| Not surprising, we do have some offsets, including a modest decline in occupancy relative to 2023 and timing of free rent, which naturally fluctuates year-to-year and is a headwind, particularly in the first quarter |
| First, there is $30 million of year-over-year decline in NOI from the well disclosed Amgen expiration at Oyster Point |
| It’s up this year, but it certainly is a little bit of a headwind as well |
| A little bit of a headwind this year in our number |
| Boards are still cautious, as Pete mentioned, is taking new space and expansions and things like that |
| I mean there may be select spaces within the portfolio that would have a negative renewal rate mark-to-market, but that was an outlier |
| That’s probably 100-plus basis points decline, so a modest decline, but nevertheless a headwind |
| In addition to the headwinds discussed already, we have included about $10 million in conservatism in our outlook for various items, including potential further capital recycling activities, proactive lease terminations and bad debt |
| But as we look out, based upon how long it takes leases to get signed, that has actually slowed a little bit |
| We have $40 million of a temporary decline in NOI at two marquee campuses that I wanted to spend a moment on |
| The first week of January is quite slow |
Please consider a small donation if you think this website provides you with relevant information